Roche Stories

Seeing the unseen with artificial intelligence

AI could change the way ophthalmologists diagnose eye conditions like diabetic macular edema.

Understanding neovascular age-related macular degeneration

Learn about neovascular age-related macular degeneration, a leading cause of vision loss for people over 60.

Just the other day, I realised I could open the fridge again

Conversations with people with SMA and their families

Healthy liver, healthy lives

The liver is your body’s chemical processing plant, a powerhouse crucial to remove toxins; but liver cancer is on the rise. Learn what we can do to change this.

Roche results for half-year 2019

When everyday counts, data makes a meaningful difference for patients

Investors reporting center

Roche in Haemophilia

Find out more about haemophilia A and how Roche is developing novel approaches to hopefully advance the management of this serious disorder.

Personalised Healthcare

Working in both Pharmaceuticals and Diagnostics, we are uniquely positioned to fit the treatment to the patients.

A conversation with Roland Beckmann, inventor of the DutaMab technology

Interview with Dutalys co-founder and inventor of the DutaMab technology platform, Roland Beckmann, on his invention and journey founding a biotech.

Shaping the future of cancer care

Combining science, partnerships and analytics in the fight against cancer.

Improving the supply chain

Gaps in the supply chain resulted in cost mark-ups putting modern cancer therapies out of reach for patients in sub-Saharan Africa.

Scaling up cancer care

Personalised healthcare is becoming a reality across the continuum of cancer care, from the nanoscale to the national.

Partnering to drive innovation in cancer immunotherapy

We’re partnering with many different stakeholders to find the most effective way for the immune system to identify and kill cancer cells.

Roche at the ASCO Annual Meeting 2019

Learn how we are working to help define the personalised cancer patient journeys of tomorrow.

Our philanthropic journey

Over 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.

How machine learning is transforming healthcare

Advanced analytics provide novel insights that could help to tackle some of the most complex problems in healthcare.

Tumour-agnostic treatments: A radical new approach to tackling cancer

Learn how tumour-agnostic approaches have the potential to change the way we diagnose, and treat, cancer in the future.

An introduction to personalised healthcare for the eye

Insights on how personalised healthcare can bring meaningful benefits to patients with retinal diseases

Inflammatory bowel diseases

We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.

Master the art of detection for skin cancer

Take a tour of our virtual gallery and learn to master the art of detection for skin cancer. It could help you save lives.

Life with NMOSD: Staying who you are with a rare disease

“Do not take life for granted. Take every moment in.”

Getting closer to cancer research's holy grail

Combining clinical and genomic data to advance personalised healthcare.

Fighting counterfeits to protect patients

For patients whose lives depend on prescription medicines, the consequences of counterfeiting are dramatic.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Small cell, big difference

Understanding what makes small cell lung cancer unique and what is being done to improve the lives of people with small cell lung cancer.

Global Access Program

According to the World Health Organization (WHO), there were 35 million people living with HIV around the world in 2012. That same year 2.5 million people became newly infected with HIV worldwide.

What is Personalised Healthcare?

Personalised healthcare is about providing the right treatment for the right patient. Fitting treatments to patients has always been the objective of medicine, of course. But only recent advances in science and technology have made this possible.

Exposing the impact of progression in multiple sclerosis

Pieter shares his experiences of progression in MS, and how virtual reality can help facilitate discussions about progression within the MS community.

Balance for better

Why is it important for businesses and society to create better gender balance? Hear the aspirations from our own people.

Roche in rare diseases

Find out what makes a rare disease rare and who is affected.

Annual Report 2018 Highlights

How digital innovation increases patient benefit in the future.

Roche on World Cancer Day

We are happy to join the global cancer community on this important day to unite behind a shared goal: to end cancer.

Elevating the patient voice in Huntington’s disease

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

Staying active despite progression: Anat’s Story

Explore Anat’s powerful message of staying active despite her progression in multiple sclerosis.

Partnering to fulfill the promise of personalised healthcare

The promise of personalised healthcare is a simple one: finding the right treatment for every patient. Through strategic partnerships, Roche is committed to fulfilling that promise.

Medical software and the value of digital health

By connecting dots between patients, physicians, medical research and more, digital health provides data-driven results to support life-changing decisions.

Women’s health

No matter what stage of life or part of the world a woman is in, knowledge is power.

Every Cancer Is Unique. Let’s Treat It That Way.

Every cancer is unique. Discover how genomic testing can reveal mutations in a cancer tumour that can guide personalised treatment decisions.

Calculating the unimaginable

Quantum computers promise to offer computing power far beyond anything we can imagine.

Decision support

A new level of certainty

Taking control of IPF: A tale of two perspectives

Rainer, who was diagnosed with idiopathic pulmonary fibrosis (IPF) after two stressful years of uncertainty, tells his story on living with IPF alongside expert advice from his doctor.

Understanding the role of the microbiome in IBD

Unlocking the mysteries of the gut’s unique and diverse environment of micro-organisms to help improve patient treatment outcomes.

The value of clinical decision support

Because patients need certainty.

A journey towards mutual understanding in IBD

A look at the importance of patient-physician communication in ulcerative colitis and Crohn’s disease, and how we are developing digital tools to help address this.

Uncovering stories of progression from the MS community

The MS community shares what they want others to know about the often invisible symptoms of MS, as well as their journey to managing its hidden impact.

Responding to natural disasters sustainably

For communities that have experienced a major natural disaster, we support community rebuilding and humanitarian projects.

Transnet-Phelophepa healthcare train

The Transnet-Phelophepa trains are mobile healthcare clinics that travel nine months out of the year to areas of rural South Africa.

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Piecing together the puzzle of IBD

Read how we are approaching personalised healthcare in IBD to support individualised care for people living with ulcerative colitis and Crohn’s disease.

What is IBD?

IBD is a group of complex, chronic conditions, characterised by prolonged inflammation of the gastrointestinal tract, which can have a long-term impact on a patient's quality of life.

Roche's personalised approach in IBD

Compare today's approach in IBD with the ideal future

Changing the colorectal cancer story

Two days after being admitted to hospital with stomach pains, Eve Bukowski woke up to the news we all fear.

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Our mission is rooted in our formula: follow the science to preserve what makes people who they are.

Why a "perfect storm" could drive personalisation of patient care

Today, scientists, researchers and doctors are looking at cancer with new eyes. We are entering a new and significant era, where treatment is being personalised even further.

Personalised Healthcare

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

Reimagining digital health regulation

For timely access to technologies that improve health decisions, health authorities are rethinking regulations for the uniquely iterative world of software.

The role of diagnostics in fertility and pregnancy

Learn more about advanced screening and diagnostics tests and their role in preconception and pregnancy.

About the importance of disease awareness

Four key factors need to be in place to successfully treat a patient, the first factor is disease awareness.

Will quantum computers solve the problems of the future?

Martin Strahm talks about the idea, the potential and the limitations of quantum computers.

Will genomics revolutionise the future of medicine?

Joanne Hackett talks about genomics, healthcare, big data and people’s hesitation to share medical data.

Hepatitis B - Aiming for cure of a killer

Hepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.

Building bridges to improve the cancer patient journey

The role of an oncology nurse navigator requires a unique combination of skills, knowledge and compassion.

ForPatients

Developed in partnership with patients, ForPatients aims to support patients on their journey.

A woman's right to know: HPV and cervical cancer

The HPV test came back positive – what now? Should women be worried? What should they do next?

Unveiling triple-negative breast cancer

Lifting the curtain on an often overlooked disease.

Striking back at stroke risk

Why less is more in atrial fibrillation management

Addressing the lack of cancer care in Pakistan

Our access to healthcare initiatives

Explore some of our access projects from around the globe.

Increasing access to healthcare

Groundbreaking advances in medical science are only meaningful when they reach the people who need them.

‘Accelerators and brakes’ to restore immune balance

Roche strategy in Immunology is to make use of the growing scientific understanding of immune pathways and to selectively manipulate these in order to restore immune balance.

Increasing access to healthcare is a global challenge

Finding sustainable solutions to the barriers to healthcare can only be achieved through collaboration.

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Improving access to hepatitis treatment in Egypt

Comprehensive access to cancer treatment in Dubai

A platform for supporting cancer patients in India

India does not have a centralised healthcare funding body and access to medicines is not universal.

Improving cancer care in Bosnia and Herzegovina

Our approach to sustainability

Let’s talk fertility

Women and their bodies may have very different ideas about the right time to have a baby.

Strengthening communities

We are committed to building stronger communities and responding to natural disasters sustainably.

Our approach to philanthropy

We engage in philanthropic activities that make a lasting impact and strengthen communities.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Making HIV testing accessible

The Global Access Programme makes HIV viral load tests and the early detection of infections in infants possible in countries that are most affected by the disease.

Our Approach to Cancer Immunotherapy

Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.

About the importance of funding

Four key factors need to be in place to successfully treat a patient, with funding being the most controversial one.

About the importance of healthcare capacity

Healthcare capacity is one of four key factors that need to be in place to successfully treat a patient.

About the importance of diagnosis

Four key factors need to be in place to successfully treat a patient, with diagnosis being one of them.

Our approach to increase access to healthcare

Access to healthcare is a complex challenge. Four key factors need to be in place to improve access to quality healthcare.

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Digital solutions supporting rheumatoid arthritis community

It has become natural for people to seek information or advice about their health online. Learn about three solutions we developed for the European RA community.

The value of diagnostics in heart failure management

Heart failure affects millions of people and despite improvement in care, management remains challenging. Biomarkers can help patients at every stage of care.

Mesothelioma: What could possibly link this rare cancer to the ill-fated Titanic?

What could possibly link this rare cancer to the ill-fated Titanic?

Busting myths in lung cancer

How much do you really know about lung cancer? Our interactive flashcards bust some common myths about lung cancer.

Expecting more for people with PPMS

Dr. Jerome de Seze, explains how recent clinical advances mean more and more people are being diagnosed with PPMS.

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

What is Life?- Live Streaming with Paul Nurse.

Watch the live stream of Nobel Prize winner Sir Paul Nurse

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Protecting against progression

Dr. Traboulsee, University of British Columbia in Vancouver, discusses the importance of brain health and early treatment for people with multiple sclerosis.

Beyond the immunity cycle

Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.

Roche in Alzheimer’s disease

Alzheimer’s disease has far-reaching impact on individuals, caregivers, families and society. Learn how Roche is tackling this looming global crisis.

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

Buttons - daily enemies for people with rheumatoid arthritis

New clothing collection designed to overcoming issues that people with RA face when getting dressed.

Rheumatoid arthritis through the lens of an Slovenian artist

A photographer captures what it means to live with the consequences of rheumatoid arthritis.

Providing a helping hand for people with rheumatoid arthritis

A collaboration with the Brazilian patient advocacy group helps to improve the quality of life of people living with RA.

Life with rheumatoid arthritis through pictures and words

The three artists captured what living with the disease means to people with rheumatoid arthritis.